Artificial Intelligence

Start-Up Cleerly Sees Path Using AI to Prevent Cardiovascular Disease

Jun 21, 2021

New York-based Cleerly has raised $43 million in a series B round and brought in $54 million to date. Cleerly is also one of a growing number of companies at the intersection of artificial intelligence and the cardiovascular sector.

CareDx Expands Digital Portfolio with Transplant Hero Acquisition

Jun 08, 2021

The acquisition continues the trend of upward mobility CareDx has experienced in recent months.

The Next Stage of Evolution for iRhythm’s Zio Patch

May 27, 2021

The San Francisco, CA-based company has won FDA clearance for a new design and upgraded artificial intelligence for the wearable cardiac monitor.

War of the Wearables: ITC Investigates AliveCor’s Claim Against Apple

May 24, 2021

AliveCor said in its claim that it wants to block the importation of all the Apple Watches in U.S. – and said the tech giant is infringing on three counts of ECG patents.

VitalConnect Adds Mobile Cardiac Telemetry to its Arsenal

May 23, 2021

The launch of the MCT platform puts VitalConnect in a league of its own.

Heru is Changing Vision Care to Meet the Needs of a Post-Pandemic World

May 21, 2021

Miami, FL-based Heru has developed an artificial intelligence-powered eye diagnostic and vision correction platform. The company recently raised $30 million in a series A round.

Medtech in a Minute: Google Wants to Analyze Your Skin Problems, and More

May 21, 2021

Pressed for time? Here's the medtech news you need most, in one minute or less.

Google's New AI-Powered Tool Gives Insight into Skin Issues

May 20, 2021

Mountain View, CA-based Google showed off the tool during I/O, its annual developer conference.

Changing the Game for Diagnosing and Treating Inflammatory Bowel Disease (IBD)

May 19, 2021

These technologies have the potential to make a real difference in the lives of IBD patients.

AI-Derived Heart Measurements Help Predict COVID-19 Mortality

May 18, 2021

The research was unveiled at the ACC.21 Scientific Sessions. Researchers used Ultromics’s cloud-based AI platform to review the data.

Keep You Informed